Aurobindo Pharma’s Q2FY25 consolidated net profit rises by 9%

11 Nov 2024 Evaluate

Aurobindo Pharma has reported results for second quarter ended September 30, 2024 (Q2FY25). 

The company has reported 29.29% rise in its net profit at Rs 537.53 crore for the quarter ended September 30, 2024 as compared to Rs 415.74 crore for the same quarter in the previous year. Total income of the company increased by 7.73% at Rs 2,947.25 crore for Q2FY25 as compared to Rs 2,735.84 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 8.65% rise in net profit at Rs 816.95 crore for Q2FY25 as compared to Rs 751.94 crore for the same quarter in the previous year. Total income of the company increased by 7.10% at Rs 7,932.07 crore for Q2FY25 as compared to Rs 7,406.40 crore for the corresponding quarter previous year.


Aurobindo Pharma Share Price

1176.65 -40.80 (-3.35%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×